Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach.
Boussios S, Karihtala P, Moschetta M, Abson C, Karathanasi A, Zakynthinakis-Kyriakou N, Ryan JE, Sheriff M, Rassy E, Pavlidis N.
Boussios S, et al. Among authors: zakynthinakis kyriakou n.
Invest New Drugs. 2020 Feb;38(1):181-193. doi: 10.1007/s10637-019-00867-4. Epub 2019 Oct 24.
Invest New Drugs. 2020.
PMID: 31650446
Review.